Dr. Reddy's Laboratories Ltd. (RDY)
12.12
-0.04
(-0.29%)
USD |
NYSE |
Aug 28, 13:30
Dr. Reddy's Laboratories Market Cap : 10.10B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 10.13B |
| August 26, 2026 | 10.18B |
| August 25, 2026 | 10.28B |
| August 24, 2026 | 10.18B |
| August 21, 2026 | 10.15B |
| August 20, 2026 | 10.09B |
| August 19, 2026 | 10.09B |
| August 18, 2026 | 10.12B |
| August 17, 2026 | 10.09B |
| August 14, 2026 | 10.22B |
| August 13, 2026 | 10.35B |
| August 12, 2026 | 10.32B |
| August 11, 2026 | 10.37B |
| August 10, 2026 | 10.12B |
| August 07, 2026 | 10.18B |
| August 06, 2026 | 10.09B |
| August 05, 2026 | 10.11B |
| August 04, 2026 | 10.08B |
| August 03, 2026 | 10.05B |
| July 31, 2026 | 9.871B |
| July 30, 2026 | 9.854B |
| July 29, 2026 | 9.796B |
| July 28, 2026 | 9.771B |
| July 27, 2026 | 9.804B |
| July 24, 2026 | 9.821B |
| Date | Value |
|---|---|
| July 23, 2026 | 9.829B |
| July 22, 2026 | 9.479B |
| July 21, 2026 | 10.46B |
| July 20, 2026 | 10.43B |
| July 17, 2026 | 10.49B |
| July 16, 2026 | 10.57B |
| July 15, 2026 | 10.63B |
| July 14, 2026 | 10.69B |
| July 13, 2026 | 10.76B |
| July 10, 2026 | 10.98B |
| July 09, 2026 | 11.57B |
| July 08, 2026 | 11.76B |
| July 07, 2026 | 12.18B |
| July 06, 2026 | 11.96B |
| July 02, 2026 | 11.97B |
| July 01, 2026 | 11.65B |
| June 30, 2026 | 12.07B |
| June 29, 2026 | 12.40B |
| June 26, 2026 | 12.84B |
| June 25, 2026 | 12.73B |
| June 24, 2026 | 12.24B |
| June 23, 2026 | 11.94B |
| June 22, 2026 | 11.61B |
| June 18, 2026 | 11.09B |
| June 17, 2026 | 10.97B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 56.91B |
| Teva Pharmaceutical Industries Ltd. | 42.52B |
| Novo Nordisk A/S | 152.10B |
| Perrigo Co. Plc | 1.996B |
| Innoviva, Inc. | 1.520B |
Market Cap Related Metrics
| PE Ratio | 27.25 |
| PS Ratio | 2.762 |
| Price to Book Value | 2.493 |
| Price to Free Cash Flow | 132.89 |
| Price | 12.12 |
| Earnings Yield | 3.67% |
| Operating PE Ratio | 27.42 |